Search for: "Sue Page" Results 1441 - 1460 of 5,261
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jul 2009, 8:00 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: FTC of Korea fines Qualcomm $208M (Korea IP Law Blog) (IP finance) Dutch judge orders Pirate Bay to block Netherland surfers (Ars Technica) (TorrentFreak) Nortel bankruptcy, sale of patents to Ericsson (IP finance) (IAM) Tenenbaum file-sharing trial: Judge rejects fair use defense; ‘tortured day of jury selection’;… [read post]
27 Feb 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Evista (Raloxifene) – US: CAFC affirms extension of 30-month stay against Teva’s generic Evista: Eli Lilly & Co v Teva Pharmas. [read post]
26 Jun 2009, 12:00 am
(IP finance) Europe European countries amp up war on piracy (TorrentFreak) France Sarkozy says he will ‘go all the way’ with 3 strikes (TorrentFreak) Germany Pirate Party enters German parliament (TorrentFreak) (Ars Technica) (IPKat) (1709 Copyright Blog) Regional Court in Hamburg orders file-hosting service, Rapidshare, to proactively filter content (TorrentFreak) (Ars Technica) Greece Public consultation for a new domain name regulation in Greece (Class 46) India… [read post]
4 Jun 2010, 5:48 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: C-32 - Canada’s new copyright bill (Ars Technica) (Michael Geist) (Michael Geist) (Michael Geist) (Michael Geist) (Excess Copyright) (Michael Geist) (TorrentFreak) Can the trademark &R&E&I&F&E&N& give right to registration of reifen.eu? [read post]
8 Apr 2007, 8:33 am
Here’s the 31-page complaint and a story from Saturday’s L.A. [read post]
23 Aug 2007, 9:25 pm
Padilla's humanity and his will to live," the 30-page complaint says. [read post]
29 Jan 2014, 2:14 pm by Cyrus Farivar
In his 11-page brief, he accused NASA of a “dereliction of duty,” and wants to compel the agency to take “100 high-resolution photographs” of the rock in question. [read post]
20 Apr 2023, 9:45 am by Andrew Cunningham
Enlarge (credit: Getty Images) The Microsoft Advertising platform will drop support for its Twitter integration starting on April 25, according to a recently updated support page. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs)… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs)… [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs)… [read post]
17 Aug 2010, 2:59 am
If you've been feeling out of sync from trying to follow the ball on genetically modified (GM) sugar beets, the ten-page order last Friday from U.S. [read post]
26 Aug 2009, 6:12 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Nexavar (Sorafenib) – India: Delhi High Court rejects Bayer complaint for patent linkage (Intellectual Property Watch) (Spicy IP) (GenericsWeb) Evista / Xigris - US: CAFC grants en banc request to challenge written description requirement: Ariad v Lilly (Patently-O) (Filewrapper) (Washington State Patent Law Blog) (Patent… [read post]
27 Mar 2024, 5:01 am by Eugene Volokh
.): John Anthony Castro filed this lawsuit on June 16, 2023, alleging that former President Donald Trump, among others, conspired to publish defamatory, verifiably false statements about him on his Wikipedia page. [read post]
10 Jun 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Afro-Indian anti-counterfeit legislation debate; Legislation prompts India to send delegation to Africa (Spicy IP) (Afro-IP) (Afro-IP) Drug seizures in Frankfurt spark fears of EU-wide pattern (Intellectual Property Watch)   General Broad plan on IP, innovation in developing countries approved at WHO (Intellectual Property… [read post]
15 Aug 2008, 4:05 pm
There are now 37 forthcoming events listed in the IPKat's lovingly updated 'Forthcoming Events' feature, which you will find in the left-hand side-bar of this weblog's front page. [read post]
20 Feb 2012, 3:00 am by Louis M. Solomon
Feb. 2012), is a 129-page decision comprehensively addressing the allegations underlying and the securities claims arising from the BP oil spill of April 20, 2010. [read post]
11 Dec 2006, 6:29 am
Judicial conduct has been under the spotlight lately with two stories hitting front pages in the last week alone. [read post]
18 Apr 2014, 1:04 pm by Lyle Denniston
  In a one-page ruling, Roberts said he was not convinced that Teva Pharmaceuticals USA, Inc., would suffer serious harm from the competition because it can later sue the generic companies for damages if its key patent on the drug Copaxone is ultimately upheld. [read post]